FDA Approved: LEVOTHYROXINE SODIUM — Supplemental Application (Lannett Company, Inc)

View source ↗

Summary

FDA approved a supplemental application for Levothyroxine Sodium from Lannett Company, Inc., reinforcing the product's existing approval via a supplemental NDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypothyroidism

Drugs mentioned

• LEVOTHYROXINE SODIUM (levothyroxine sodium)

Snippet

SUPPL AP for LEVOTHYROXINE SODIUM (LEVOTHYROXINE SODIUM)